UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934
 
 
 
Date of Report (Date of earliest event reported)
July 30, 2015
 
 
 
 
THE PROCTER & GAMBLE COMPANY
(Exact name of registrant as specified in its charter)
 
Ohio
 
1-434
 
31-0411980
(State or other jurisdiction
of incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)
 
One Procter & Gamble Plaza, Cincinnati, Ohio
 
45202
(Address of principal executive offices)
 
Zip Code
 
(513) 983-1100
 
45202
(Registrant's telephone number, including area code)
 
Zip Code
 
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
ITEM 7.01    REGULATION FD DISCLOSURE
 
On July 30, 2015, The Procter & Gamble Company (the "Company") issued a press release announcing its fourth quarter and fiscal year results and hosted a conference call related to those results.  The Company is furnishing on Form 8-K a series of slides referenced in the conference call, which are also posted on the Company's website. This 8-K is being furnished pursuant to Item 7.01, "Regulation FD Disclosure."
 
 
 SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
THE PROCTER & GAMBLE COMPANY
 
 
BY:  /s/ Susan S. Whaley                    
           Susan S. Whaley
           Assistant Secretary
           July 30, 2015
 
 
EXHIBIT(S)
 
99.    Informational Slides Provided by The Procter & Gamble Company dated July 30, 2015.


 July 30, 2015  Procter & Gamble Earnings Release:Q4 FY 2015 Results 
 

 Fiscal Year 2015Business Results 
 

 Fiscal Year 2015 ResultsOrganic Sales Growth  1%  3%  3% 
 

 Fiscal Year 2015 ResultsCore EPS Growth*  * Excludes Pet Care & Batteries 
 

 Fiscal Year 2015 ResultsConstant Currency Core EPS Growth*  * Excludes Pet Care & Batteries 
 

 Returning Value to Shareholders  $ billions  FY 2015  Past 10 FY’s  Dividends  7.3  55.7  Share Repurchase  4.6   55.7*  Value to Shareholders  11.9  111.4  % of Adjusted Net Earnings  105%  94%  * Excludes Gillette repurchases 
 

 Apr – Jun 2015 (Q4 FY 15)Business Results 
 

 
 Apr – Jun 15 (Q4 FY 15) ResultsOrganic Sales Growth*  Organic sales were flat with 3 of 5 reporting segments growing versus prior year.  2%  * Restated for Batteries & PetCare  0%  2%  2% 

 Apr – Jun 15 (Q4 FY 15) ResultsOrganic Sales Growth*  Organic sales were flat with 3 of 5 reporting segments growing versus prior year.  2%  * Restated for Batteries & PetCare  0%  2%  2% 
 
 Apr – Jun 15 (Q4 FY 15) ResultsOrganic Sales Growth*  Organic sales were flat with 3 of 5 reporting segments growing versus prior year.  2%  * Restated for Batteries & PetCare  0%  2%  
 Apr – Jun 15 (Q4 FY 15) ResultsMarket Share   Global value share ~21% % of Sales Holding/Growing Share ~45% 
 

 Apr – Jun 15 (Q4 FY 15) ResultsCore EPS Growth*  Core EPS includes 90 basis points of operating margin improvement driven by productivity savings.  * Restated for Batteries & Pet Care  -8%  3%  22%  8% 
 

 Apr – Jun 15 (Q4 FY 15) ResultsCurrency Neutral Core EPS Growth*  Excluding the impact of foreign exchange, currency-neutral core earnings per share increased 22% for the quarter.   * Restated for Batteries & Pet Care  28% 
 

 Results To-DateNon-Core Restructuring Spending*  * Restated for Pet Care & Batteries    FY 15          ($MM Before Tax)  JAS  OND  JFM  AMJ  FY  Cost of Goods Sold  93  77  161  202  533  SG&A   2  18   92  79  191  Total Non-Core Restructuring  95  95  253  281  724 
 

 
 Estimated Restated FY ‘15 Core EPS  FY ‘15 Core EPS – As Reported $4.02Adjustments: Results* Restated to Disc Ops (0.25) FY ‘15 Core EPS - Estimated Restated $3.77  * Includes results for the Salon Professional, Fragrance, Cosmetics and Hair Color categories 
 Estimated Restated FY ‘15 Core EPS  * Includes results for the Salon Professional, Fragrance, Cosmetics and Hair Color categories    Q1  Q2  Q3  Q4  FY 15  As Reported  1.04  1.06  0.92  1.00  4.02  Adjustments for Results* Restated to Disc Ops  (0.05)  (0.11)  (0.03)  (0.06)  (0.25)  Estimated Restated  0.99  0.95  0.89  0.94  3.77  Informational 8K will be available in September with final restatements.Please note that these numbers are estimates. 
 

 Estimated Restated FY ‘15 Core EPS  * Includes results for the Salon Professional, Fragrance, Cosmetics and Hair Color categories    Q1  Q2  Q3  Q4  FY 15  As Reported  1.04  1.06  0.92  1.00  4.02  Adjustments for Results* Restated to Disc Ops  (0.05)  (0.11)  (0.03)  (0.06)  (0.25)  Estimated Restated  0.99  0.95  0.89  0.94  3.77  Informational 8K will be available in September with final restatements.Please note that these numbers are estimates. 
 
 
 Business Segments 
 

 Apr – Jun 15 (Q4 FY 15) ResultsBeauty, Hair & Personal Care Segment  +5% Pricing, -1% MixOrganic Sales: h Low single digits in Developed markets, i Mid-single digits in Developing marketsGlobal value share declined 0.7 points versus year agoNet Earnings: Productivity improvements and pricing were more than offset by volume decline, mix hurts and currency headwinds.  Organic Sales  Organic Volume  Net Earnings  -1%  -5%  -1% 
 

 By Category  Organic Sales Growth IYA        Global  Developed  Developing  Hair Care  ~=  ~=  ~=  Skin Care  -  -  -  Personal Cleansing  -  ~=  -  Deodorants  +  +  -  Cosmetics  ~=  +  -  Prestige  -  +  -  Salon Professional  +  +  +  Apr – Jun 15 (Q4 FY 15) ResultsBeauty, Hair & Personal Care – Organic Sales   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than1%. 
 

 Hair Care organic sales were in-line with year ago. Globally, growth on Head & Shoulders was off-set by declines in smaller Hair Care and Color brands. For FY ‘15, U.S. Pantene grew sales mid-single digits, and P3M value share was up nearly 1 point.Skin Care organic sales declined due to competitive challenges across regions. Antiperspirants and deodorants organic sales were up high single digits. Developed market sales increased double digits with continued strength in Old Spice and were partially off set by Developing market sales decline due to a high base period from the Old Spice expansion.Personal Cleansing organic sales were down due to declines in Developing markets largely behind impacts from trade inventory corrections in China.Cosmetics organic sales were down low single digits. Mid-single digit sales growth in Developed markets behind a focus on higher tier products and lower trade investments was more than offset by declines in Developing markets due to negative geographic mix.Organic sales in Prestige decreased low single digits. Strong sales growth in SKII was more than offset by declining sales in Fragrances due to lower levels of product innovation versus the base period.Salon Professional organic sales were up mid-single digits driven by pricing, innovation and a low base period.  Apr – Jun 15 (Q4 FY 15) ResultsGlobal Beauty, Hair & Personal Care Highlights 
 

 Apr – Jun 15 (Q4 FY 15) ResultsGrooming Segment  +4% Pricing, -4% MixOrganic Sales: i High singles in Developed markets, i Mid-singles in Developing marketsGlobal value share declined 0.3 points versus year agoNet Earnings: Price increases and productivity savings were more than offset by volume declines, mix hurts and currency headwinds.  -7%  -34%  Organic Sales  Organic Volume  Net Earnings  -7% 
 

 By Category  Organic Sales Growth IYA        Global  Developed  Developing  Blades & Razors  -  -  -  Pre & Post Shave  +  ~=  +  Braun & Appliances  ~=  ~=  ~=  Apr – Jun 15 (Q4 FY 15) ResultsGrooming – Organic Sales   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than1%. 
 

 Global Blades & Razors organic sales declined in Developed and Developing markets driven by a high base period from the FlexBall launch in North America and FIFA World Cup innovation across regions, prior quarter inventory builds for the FlexBall launch in Europe, increased competitive activities in North America, and inventory adjustments after recent devaluation price increases in Russia, Brazil and Japan.Appliances organic sales were up slightly as growth from recent innovation, like the launch of Series 9 shavers was off set by promotional investments.  Apr – Jun 15 (Q4 FY 15) ResultsGlobal Grooming Highlights 
 

 Apr – Jun 15 (Q4 FY 15) ResultsHealth Care Segment   +4% Pricing, +3% MixOrganic Sales: h Mid-singles in Developed markets, h Mid-singles in Developing markets Global value share declined 0.5 points versus year agoNet Earnings: Price increases, mix helps, and productivity savings were more than offset by volume declines and currency headwinds.  Organic Sales  Organic Volume  Net Earnings  -3%  -1%  4% 
 

 By Category  Organic Sales Growth IYA        Global  Developed  Developing  Oral Care  +  +  +  Personal Health Care  +  ~=  +  Apr – Jun 15 (Q4 FY 15) ResultsHealth Care – Organic Sales   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than1%. 
 

 Oral Care organic sales increased mid-single digits. Developed market sales were up mid-singles due to premium innovation and Developing markets grew low single digits behind premium innovation and pricing.Personal Health Care sales increased low single digits with Developing market sales up high singles behind price increases. Developed market sales were flat as growth in the U.S. from innovation and the end of a strong cough/cold season was offset by declines in Prilosec due to a new market entrant.  Apr – Jun 15 (Q4 FY 15) ResultsGlobal Health Care Highlights 
 

 Apr – Jun 15 (Q4 FY 15) ResultsFabric & Home Care Segment  +2% Pricing, Flat MixOrganic Sales: h Mid-singles in Developed markets, i Low singles in Developing marketsGlobal value share declined 0.3 points versus year agoNet Earnings: Productivity savings, pricing and commodity improvements were offset by currency headwinds and negative mix.  Organic Sales  Organic Volume  0%   3%   1%   Net Earnings 
 

 By Category  Organic Sales Growth IYA        Global  Developed  Developing  Fabric Care  +  +  -  Home Care  +  +  +  P&G Professional  +  +  -  Apr – Jun 15 (Q4 FY 15) ResultsFabric & Home Care – Organic Sales   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than1%. 
 

 Fabric Care organic sales increased low single digits. Developed market sales were up mid-single digits with solid growth in the U.S. behind innovation and in Japan due to a low base period due to the VAT tax increase. Developing market sales declined behind competitive activity, inventory corrections from devaluation pricing, minor brand divestitures and the deprioritization of non-strategic forms such as bars.U.S. Fabric Care value share grew nearly 1 point behind the launch of our innovation bundle in the March quarter and additional investments.Home Care organic sales grew mid-single digits. Developed market sales were up mid-singles driven by growth from premium innovation in the U.S. and Developing market sales increased low single digits due to pricing and strong growth of dish care.  Apr – Jun 15 (Q4 FY 15) ResultsGlobal Fabric & Home Care Highlights 
 

 Apr – Jun 15 (Q4 FY 15) ResultsBaby, Feminine & Family Care Segment  +3% Pricing, +2% MixOrganic Sales: h Mid-singles in Developed markets, i Mid-singles in DevelopingGlobal value share declined 1.0 points versus year agoNet Earnings: Pricing, lower commodity costs and productivity savings were more than offset by currency headwinds and marketing investments.  Organic Sales  Organic Volume 
 

 By Category  Organic Sales Growth IYA        Global  Developed  Developing  Baby Care  ~=  +  -  Feminine Care  ~=  +  -  Family Care  +  +  -  Apr – Jun 15 (Q4 FY 15) ResultsBaby, Feminine & Family Care – Organic Sales   + represents growth above 1%, ~= represents growth of 1% to decline of 1%; - represents decline greater than1%. 
 

 Baby Care organic sales were in line with year ago as solid growth in the U.S was partially offset by inventory adjustments and consumer demand reductions due to pricing for currency devaluation and trade terms changes in developing markets. In the U.S., baby care value share was up over 1 point versus year ago behind innovation driven up-tiering, with Swaddlers growing value share over 2 points versus last year.Feminine Care organic sales were in-line with year ago. Mid-single digit sales growth in Developed markets due to the Adult Incontinence launch in 10 markets, including North America, U.K., France, Netherlands, Belgium and Germany, and new innovation on the base business in the U.S. was off set by volume reductions due to devaluation pricing in Developing markets.Family Care organic sales were up mid-single digits as growth in the U.S. behind value interventions was partially off set by declines in Mexico as we focus the portfolio on the top tier.  Apr – Jun 15 (Q4 FY 15) ResultsGlobal Baby, Feminine & Family Care Highlights 
 

 Fiscal Year 2016 Guidance 
 

 FY 2016 Guidance*Organic Sales    FY’16  Organic Sales Growth  In-line to Up Low Single Digits  Currency  -4% to -5%  Minor brand divestitures  Modest Drag  All-in Sales Growth  Down Low to Mid-Single Digits  * Guidance assumes that Batteries & transitioning Beauty businesses are accounted for as discontinued operations 
 

 FY 2016 Guidance*EPS Growth  FY’16 (vs. restated FY ’15)    Core Operating Income Growth  Up Mid to High Single Digits  Core Earnings Per Share Growth  Down Slightly to Up Mid-Single Digits  All-in Earnings Per Share Growth  +53% to +63%      Other Items  Impact on Core EPS  Venezuela accounting change  $(0.05) to (0.06)  Beauty deal transition costs  $(0.02) to (0.03)  Non Operating income  -2% to -3%  Tax Rate  -4%  Foreign Exchange  -3% to -4%  Commodities  Modest Benefit  * Guidance assumes that Batteries & transitioning Beauty businesses are accounted for as discontinued operations 
 

 FY 2016 Guidance*EPS Growth    FY’16  Core Operating Income Growth  Up Mid to High Single Digits  Core Earnings Per Share Growth  Down Slightly to Up Mid-Single Digits  All-in Earnings Per Share Growth  +53% to 63%      Other Items:    Venezuela Deconsolidation  $(0.05) to (0.06)  Beauty deal transition costs  $(0.02) to (0.03)  Non Operating income  $(0.09) to (0.10)  Tax Rate  $(0.16)  Foreign Exchange  $(0.12) to (0.15)  Commodities  Modest Benefit  * Guidance assumes that Batteries & transitioning Beauty businesses are accounted for as discontinued operations 
 
 FY 2016 GuidanceCash Generation & Usage  Free Cash Flow Productivity: 90-100%Capital Spending, % Sales: 5% to 6%Dividends: $7B+Share Retirement/Repurchases: $8B to $9B  * Shares retired at the close of the Duracell transaction. 
 

 

 Forward Looking Statements  Certain statements in this release or presentation, other than purely historical information, including estimates, projections, statements relating to our business plans, objectives and expected operating results, and the assumptions upon which those statements are based, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements generally are identified by the words "believe," "project," "anticipate," "estimate," "expect," "intend," "strategy," "future," "opportunity," "plan," "may," "should," "will," "would," "will be," "will continue," "will likely result," and similar expressions. Forward-looking statements are based on current expectations and assumptions, which are subject to risks and uncertainties that may cause results to differ materially from those expressed or implied in the forward-looking statements. We undertake no obligation to update or revise publicly any forward-looking statements, whether because of new information, future events or otherwise. Risks and uncertainties to which our forward-looking statements are subject include, without limitation: (1) the ability to successfully manage global financial, operational and manufacturing risks, including, among others, (a) an increasingly volatile economic environment, with potentially significant disruptions and reduced market growth rates, (b) foreign currency fluctuations, (c) significant credit or liquidity issues, (d) debt, currency exposure and repatriation issues in countries with currency exchange, import authorization or pricing controls (such as Venezuela, Argentina, China, India and Egypt), (e) maintaining key manufacturing and supply sources (including sole supplier and sole manufacturing plant arrangements), and (f) managing disruption of business due to factors outside of our control, such as natural disasters and acts of war or terrorism; (2) the ability to successfully manage cost fluctuations and pressures, including commodity prices, raw materials, labor costs, energy costs and pension and health care costs, and achieve cost savings described in our announced productivity plan; (3) the ability to stay on the leading edge of innovation, obtain necessary intellectual property protections and successfully respond to technological advances attained by, and patents granted to, competitors; (4) the ability to compete with our local and global competitors by successfully responding to competitive factors, including prices, promotional incentives and trade terms for products; (5) the ability to manage and maintain key customer relationships; (6) the ability to protect our reputation and brand equity by successfully managing real or perceived issues, including concerns about safety, quality, efficacy or similar matters that may arise; (7) the ability to successfully manage the financial, legal, reputational and operational risk associated with third party relationships, such as our suppliers, contractors and external business partners; (8) the ability to rely on and maintain key information technology systems and networks (including Company and third-party systems and networks) and maintain the security and functionality of such systems and networks and the data contained therein; (9) the ability to successfully manage regulatory, tax and legal requirements and matters (including, without limitation, product liability, intellectual property, price controls, import restrictions, accounting standards and environmental and tax policy) and to resolve pending matters within current estimates; (10) the ability to successfully manage our portfolio optimization strategy, as well as ongoing acquisition, divestiture and joint venture activities, to achieve the Company's overall business strategy, without impacting the delivery of base business objectives; (11) the ability to successfully achieve productivity improvements and manage ongoing organizational changes, while successfully identifying, developing and retaining particularly key employees, especially in key growth markets where the availability of skilled or experienced employees may be limited; and (12) the ability to generate sufficient income and cash flow to allow the Company to effect the expected share repurchases and dividend payments. For additional information concerning factors that could cause actual results to materially differ from those projected herein, please refer to our most recent 10-K, 10-Q and 8-K reports. 
 

The Procter & Gamble Company Regulation G Reconciliation of Non-GAAP Measures

In accordance with the SEC's Regulation G, the following provides definitions of the non-GAAP measures used in Procter & Gamble's July 30, 2015 earnings call and associated slides and the reconciliation to the most closely related GAAP measure.   The measures provided are as follows:
 
1.
Organic Sales Growth—pages 1 and 2
2.
Core EPS and Currency-Neutral Core EPS—pages 3-5
3.
Core Operating Profit Margin—page 6
4.
Core Gross Margin—page 6
5.
Core Selling, General & Administrative Expenses (SG&A) as a % of Net Sales—page 6
6.
Core Effective Tax Rate—page 7
7.
Adjusted Free Cash Flow—page 7
8.
Adjusted Free Cash Flow Productivity—page 8

1. Organic Sales Growth: Organic sales growth is a non-GAAP measure of sales growth excluding the impacts of acquisitions, divestitures and foreign exchange from year-over-year comparisons.  We believe this provides investors with a more complete understanding of underlying sales trends by providing sales growth on a consistent basis.  Organic sales is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

The reconciliation of reported sales growth to organic sales is as follows:

Three Months Ended June 30
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition/
Divestiture Impact*
 
Organic Sales Growth
Beauty, Hair and Personal Care
(10)%
 
8%
 
1%
 
(1)%
Grooming
(18)%
 
11%
 
0%
 
(7)%
Health Care
(6)%
 
10%
 
0%
 
4%
Fabric Care and Home Care
(7)%
 
9%
 
1%
 
3%
Baby, Feminine and Family Care
(7)%
 
8%
 
0%
 
1%
Total P&G
(9)%
 
(9)%
 
0%
 
0%


Organic Sales
Prior Periods (Restated for Batteries Discontinued Operations)

 
Total Company
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition/ Divestiture Impact*
 
Organic Sales Growth
FY 2015
(5)%
 
6%
-%
 
1%
FY 2014
-%
 
3%
 
0%
 
3%
FY 2013
1%
 
2%
 
-%
 
3%


 
Total Company
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition/ Divestiture Impact*
 
Organic Sales Growth
AMJ 2014
(1)%
 
2%
 
1%
 
2%
JAS 2014
-%
 
1%
 
1%
 
2%
OND 2014
(4)%
 
5%
 
1%
 
2%
JFM 2015
 
(8)%
 
 
8%
 
 
1%
 
 
1%
 
*Acquisition/Divestiture Impact includes volume and mix impacts of acquired and divested businesses, as well as rounding impacts necessary to reconcile net sales to organic sales.
 

Total P&G
 
Net Sales Growth
 
Foreign Exchange Impact
 
Acquisition/ Divestiture Impact*
 
Organic Sales Growth
FY 2016 Estimate
 
Down low-to-mid single digits
 
Approximately 5%
 
0%
 
In line to up low single digits

*Acquisition/Divestiture Impact includes volume and mix impacts of acquired and divested businesses, as well as rounding impacts necessary to reconcile net sales to organic sales.


The core earnings measures included in the following reconciliation tables refer to the equivalent GAAP measures adjusted as applicable for the following items:
charge in 2015 related to the change in accounting for our Venezuelan subsidiaries
charges for incremental restructuring due to increased focus on productivity and cost savings,
charges  for balance sheet impacts from the devaluation of the foreign currency exchange rate in Venezuela and
charges for certain European legal matters. 
 
We do not view these items to be part of our sustainable results.  We believe that these Core measures provide an important perspective of underlying business trends and results and provide a more comparable measure of year-on-year earnings per share growth.  Core EPS is also one of the measures used to evaluate senior management and is a factor in determining their at-risk compensation.

2. Core EPS and Currency-neutral Core EPS:  Core EPS is a measure of the Company's diluted net earnings per share from continuing operations adjusted as indicated below.

Currency-neutral Core EPS is a measure of the Company's Core EPS excluding the incremental current year impact of foreign exchange.  We believe the currency-neutral Core EPS measure provides a more comparable view of year-on-year earnings per share growth.  The table below provides a reconciliation of diluted net earnings per share to Core EPS and Core EPS to Currency-neutral Core EPS:

   Three Months Ended June 30
   
2015
 
2014
Diluted Net Earnings Per Share from Continuing Operations
 
$
0.22
 
$
0.87
Incremental Restructuring
   
0.07
   
0.04
  Charges for European Legal Matters
   
(0.01)
   
0.02
  Venezuela Devaluation
   
0.71
     
  Rounding
   
0.01
     
Core EPS
 
$
1.00
 
$
0.93
Percentage change vs. prior period
   
8%
     
Currency Impact to Earnings
 
$
0.13
     
Currency-Neutral Core EPS
 
$
1.13
     
Percentage change vs. prior period
   
22%
     

Note – All reconciling items are presented net of tax.  Tax effects are calculated consistent with the nature of the underlying transaction.
 

 
Total P&G
 
Diluted EPS Growth
 
Impact of Incremental Non-Core Items
 
Core EPS Growth
FY 2016 (Estimate)
 
53% to 63%
 
(47)% to (64)%
 
(1)% to 6%


Core EPS and Currency-Neutral Core EPS
Prior Periods (Restated for Batteries Discontinued Operations)
           
   
AMJ 14
 
AMJ 13
 
JAS 14
 
JAS 13
OND 14
 
OND 13
 
JFM 15
JFM 14
FY15 FY14 FY 13
Diluted Net Earnings Per Share from Continuing Operations, attributable to P&G
 
$
0.87  
$
0.61
 
$
0.97
 
$
1.00
$
1.02
 
$
1.12
 
$
0.85
$
0.87
$ 3.06 $ 3.86 $ 3.71
Incremental Restructuring
    0.04    
0.01
   
0.03
   
0.03
 
0.03
   
0.02
   
0.07
 
0.04
0.20 0.12 0.17
Venezuela B/S Remeasurement & Devaluation Impacts
-
0.04
- -
0.04
- -
0.10
0.04 0.09 0.08
Venezuela Deconsolidation - - - - - - - - 0.71 - -
Charges for Pending European Legal Matters
   
0.02
   
-
   
0.04
   
-
 
0.01
   
-
 
-
 
-
0.01 0.02 0.05
Goodwill & Intangible Impairment
   
-
   
0.10
   
-
   
-
 
-
   
-
   
-
 
-
- - 0.10
Rounding
    -
 
 
-
   
(0.01)
   
-
 
-
   
(0.01)
   
-
 
(0.01)
- - -
Core EPS
 
$
0.93
 
$
0.76
 
$
1.04
 
$
1.01
$
1.06
 
$
1.15
 
$
.92
$
1.00
$ 4.02 $ 4.09 $ 3.89
Percentage change vs. prior period
   
22%
 
       
3%
       
(8)%
         
(8)%
  (2)% 5% 6%
Currency Impact to Earnings
   
0.04
         
0.07
       
0.16
         
0.18
  0.53 0.34 0.16
Currency-Neutral Core EPS
 
$
0.97
       
$
1.11
     
$
1.22
       
$
1.10
$ 4.55 $ 4.43 $ 4.05
Percentage change vs. prior period
   
28%
 
       
10%
       
6%
         
10%
  11% 14% 10%
 
 

3. Core Operating Profit Margin:  This is a measure of the Company's operating margin adjusted for items as indicated below.
 
AMJ 15
 
AMJ 14
 
FY 15
 
FY 14
Operating Profit Margin
5.2%
 
16.1%
 
15.5%
 
18.3%
   Incremental Restructuring
1.5%
 
0.7%
 
0.9%
 
0.5%
   Venezuela Charge
11.4%
 
—%
 
2.7%
 
—%
   Venezuela Balance Sheet Revaluation and  Devaluation
—%
 
—%
 
0.2%
 
0.4%
   Charges for European Legal Matters
(0.1)%
 
0.3%
 
—%
 
0.1%
   Rounding
0.1%
 
0.1%
 
—%
 
—%
Core Operating Profit Margin
18.1%
 
17.2%
 
19.3%
 
19.3%
Basis Point Change
90
   
 

4. Core Gross Margin:  This is a measure of the Company's gross margin adjusted for items as indicated below.
 
AMJ 15
 
AMJ 14
 
FY 15
 
FY 14
Gross Margin
48.0%
 
47.5%
 
49.0%
 
49.1%
   Incremental Restructuring
1.1%
 
0.5%
 
0.7%
 
0.4%
   Rounding
           
(0.1)%
Core Gross Margin
49.1%
 
48.0%
 
49.7%
 
49.4%
Basis Point Change
110
     
30
   


5. Core Selling, General and Administrative Expense (SG&A) as a percentage of sales:  This is a measure of the Company's SG&A as a percentage of sales adjusted for items as indicated below.
 
 
AMJ 15
 
AMJ 14
 
FY 15
 
FY 14
SG&A as a % of NOS
31.3%
 
31.4%
 
30.9%
 
30.8%
   Incremental Restructuring
(0.4)%
 
(0.2)%
 
(0.3)%
 
(0.2)%
   Venezuela Balance Sheet Revaluation and  Devaluation
—%
 
—%
 
(0.2)%
 
(0.4)%
   Charges for European Legal Matters
0.1%
 
(0.3)%
 
—%
 
(0.1)%
   Rounding
       
0.1%
 
0.1%
Core SG&A as a % of NOS
31.0%
 
30.9%
 
30.5%
 
30.2%
Basis Point Change
10
     
30
   

6. Core Tax Rate:  This is a measure of the Company's tax rate on continuing operations adjusted for items as indicated below.
 
 
AMJ 15
 
AMJ 14
 
FY 15
 
FY 14
Effective Tax Rate
49.6%
 
18.8%
 
24.6%
 
21.1%
   Incremental Restructuring
0.5%
 
0.2%
 
0.1%
 
(0.1)%
   Charges for European Legal Matters
0.1%
 
(0.3)%
 
—%
 
(0.1)%
   Venezuela Balance Sheet Revaluation and  Devaluation
—%
 
—%
 
0.1%
 
(0.3)%
   Venezuela Charge
(31.2)%
 
—%
 
(3.8)%
 
—%
   Rounding
0.1%
 
—%
 
(0.1)%
 
—%
Core Tax Rate
19.1%
 
18.7%
 
20.9%
 
20.6%
Basis Point Change
40
     
30
   


7. Adjusted free cash flow:  Adjusted free cash flow is defined as operating cash flow less capital spending excluding tax payments for the Pet divestiture.  We view adjusted free cash flow as an important measure because it is one factor used in determining the amount of cash available for dividends and discretionary investment.  The reconciliation of adjusted free cash flow is provided below (amounts in millions):


 
Operating Cash Flow
Capital Spending
Free Cash Flow
Cash Tax Payment - Pet Sale
Adjusted Free Cash Flow
Three Months Ended    June 30, 2015
$3,988
$(1,274)
$2,714
$183
$2,897
 
 
Operating Cash Flow
Capital Spending
Free Cash Flow
Cash Tax Payment - Pet Sale
Adjusted Free Cash Flow
FY 2015
$14,608
$(3,736)
$10,872
$729
$11,601



8. Adjusted free cash flow productivity:  Adjusted free cash flow productivity is defined as the ratio of adjusted free cash flow to net earnings excluding impairment charges.  The Company's long-term target is to generate annual free cash flow at or above 90 percent of net earnings.  Adjusted free cash flow productivity is also a measure used to evaluate senior management and is a factor in determining their at-risk compensation.  The reconciliation of adjusted free cash flow productivity is provided below:
 
 
Adjusted Free Cash Flow
Net Earnings
Impairment & Venezuela Charges
Net Earnings Excl.
Impairment Charges
Adjusted Free Cash Flow Productivity
Three Months Ended June 30, 2015
$2,897
$538
$2,205
$2,743
106%
 
 
Adjusted Free Cash Flow
Net Earnings
Impairment & Venezuela Charges
Net Earnings Excl.
Impairment Charges
Adjusted Free Cash Flow Productivity
FY 2015
$11,601
$7,144
$4,187
$11,331
102%


Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Procter and Gamble Charts.
Procter and Gamble (NYSE:PG)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Procter and Gamble Charts.